This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—
In The Journal, October 23, there is published a report of the Committee on Public Health Relations of the New York Academy of Medicine, on Community Provision for the Serum Treatment of Pneumococcic Pneumonias.In the paragraph on page 1326 describing the procedure for general distribution of antipneumococcus serum in Massachusetts, it states that no serum is given until the laboratory report indicates that the patient for whom it is requested is suffering from type I or type II infection and that only for patients who have been ill for not more than four days.That was our practice up to March 1937, when the restriction as to the day of disease on which treatment with serum could be begun was withdrawn.We have also made type V serum available on the same basis.
Chadwick HD. DISTRIBUTION OF ANTIPNEUMOCOCCUS SERUM IN MASSACHUSETTS. JAMA. 1937;109(23):1926. doi:10.1001/jama.1937.02780490064028
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: